EWA
BIIB icon

EverSource Wealth Advisors’s Biogen BIIB Stock Holding History

EverSource Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$583K Buy
3,178
+780
+33% +$144K 0.02% 537
2025
Q4 		$422K Buy
2,398
+151
+7% +$24.7K 0.02% 596
2025
Q3 		$315K Buy
2,247
+243
+12% +$32.8K 0.01% 706
2025
Q2 		$252K Buy
2,004
+1,012
+102% +$126K 0.01% 760
2025
Q1 		$136K Sell
992
-456
-31% -$65.2K 0.01% 799
2024
Q4 		$221K Buy
1,448
+1,258
+662% +$212K 0.01% 620
2024
Q3 		$36.8K Sell
190
-34
-15% -$7.11K ﹤0.01% 1194
2024
Q2 		$47.8K Sell
224
-49
-18% -$10.6K ﹤0.01% 1110
2024
Q1 		$58.6K Sell
273
-222
-45% -$52K ﹤0.01% 911
2023
Q4 		$128K Sell
495
-25
-5% -$6.14K 0.01% 561
2023
Q3 		$134K Sell
520
-3
-0.6% -$802 0.01% 485
2023
Q2 		$149K Sell
523
-14
-3% -$4.17K 0.02% 460
2023
Q1 		$149K Sell
537
-5
-0.9% -$1.38K 0.02% 437
2022
Q4 		$150K Buy
542
+200
+58% +$56.5K 0.02% 404
2022
Q3 		$92K Buy
342
+278
+434% +$59K 0.02% 449
2022
Q2 		$13K Buy
64
+20
+45% +$4.09K ﹤0.01% 951
2022
Q1 		$9K Sell
44
-67
-60% -$14.6K ﹤0.01% 1000
2021
Q4 		$27K Buy
+111
New +$28.5K 0.01% 563

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EverSource Wealth Advisors's BIIB Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Biogen (BIIB) stake by 33% in Q1 2026, buying an estimated $144K and bringing the position to 3,178 shares worth $583K. The position accounts for 0.02% of the portfolio, ranked #537.

EverSource Wealth Advisors first reported a position in BIIB in Q4 2021 and has held it in 18 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • EverSource Wealth Advisors held 3,178 shares of Biogen worth $583K as of Q1 2026.
  • EverSource Wealth Advisors bought 780 Biogen shares in Q1 2026, an estimated $144K.
  • Biogen made up 0.02% of EverSource Wealth Advisors's portfolio in Q1 2026, its #537 holding.
  • EverSource Wealth Advisors first reported a position in Biogen in Q4 2021 and has held it in 18 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.